SCHEMBL31332776

SCHEMBL31332776

COC(C)(CNC(=O)Nc1cccc(C)c1)c1cccc(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
POLB P06746 3/20 0.47
EPHX1 P07099 3/20 0.46
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
KCNK3 O14649 1/20 0.44
KCNK9 Q9NPC2 1/20 0.44
RAF1 P04049 2/20 0.44
HPGD P15428 1/20 0.44
CNR1 P21554 1/20 0.44
SAE1 Q9UBE0 1/20 0.43
UBA2 Q9UBT2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31332621 0.88 HTT (0.55) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL31332681 0.88 HTT (0.55) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL31332735 0.85 FADS1 (0.47) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL31332672 0.84 P2RX1 (0.50) NPC1RAB9ASMN1; SMN2POLBLMNA
SCHEMBL31332728 0.83 IDH1 (0.44) ALDH1A1NPC1RAB9APOLBHPGD
SCHEMBL31332818 0.77 EPHX1 (0.50) EPHX1MAPT
SCHEMBL23453347 0.76 KMT2A (0.63) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL31332799 0.76 POLB (0.53) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL31332801 0.76 EPHX2 (0.49) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL31332653 0.76 EPHX2 (0.49) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709708-A1 NOVEL CARBOXAMIDE DERIVATIVES ANGELINI PHARMA S.P.A. (IT) 2026-03-18 EP disclosed
WO-2024233603-A1 NOVEL CARBOXAMIDE DERIVATIVES ICAGEN, LLC (US) 2024-11-14 WO disclosed